Birdwatch Note
2024-11-22 20:35:52 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
接種直後に免疫が低下し、凄く感染する、との動画の主張は統制された研究では一般に確認されておらず対照と明確な違いは存在しません。 例えばファイザー・モデルナのランダム化比較試験の接種後 https://news.yahoo.co.jp/articles/eebd2f1d439eae3a758b8d5313203628877cf76d/images/000 Lancetのファイザーワクチンの全員定期検査研究(図2 https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00790-X/fulltext イスラエルのNEJMのマッチング研究(図2 https://www.nejm.org/doi/pdf/10.1056/NEJMoa2101765 なお２回接種後２週間後以降当面の期間に有効性が90%程度なのは2021年前半頃に流行したアルファ変異に対する販売後の有効性データのメタアナリシスでも確認されています(図1 https://link.springer.com/article/10.1186/s12916-022-02397-y#Fig1 日本でも下記の報告でアルファ変異に対する有効性95%を報告しています(表3b https://www.niid.go.jp/niid/ja/2019-ncov/2484-idsc/10614-covid19-55.html
Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1860034936847405376
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1860059648021397816
- noteId - 1860059648021397816
- participantId -
- noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
- createdAtMillis - 1732307752982
- tweetId - 1860034936847405376
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 接種直後に免疫が低下し、凄く感染する、との動画の主張は統制された研究では一般に確認されておらず対照と明確な違いは存在しません。 例えばファイザー・モデルナのランダム化比較試験の接種後 https://news.yahoo.co.jp/articles/eebd2f1d439eae3a758b8d5313203628877cf76d/images/000 Lancetのファイザーワクチンの全員定期検査研究(図2 https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00790-X/fulltext イスラエルのNEJMのマッチング研究(図2 https://www.nejm.org/doi/pdf/10.1056/NEJMoa2101765 なお２回接種後２週間後以降当面の期間に有効性が90%程度なのは2021年前半頃に流行したアルファ変異に対する販売後の有効性データのメタアナリシスでも確認されています(図1 https://link.springer.com/article/10.1186/s12916-022-02397-y#Fig1 日本でも下記の報告でアルファ変異に対する有効性95%を報告しています(表3b https://www.niid.go.jp/niid/ja/2019-ncov/2484-idsc/10614-covid19-55.html
Note Ratings
| rated at | rated by | |
| 2024-11-23 22:16:14 -0600 | Rating Details | |
| 2024-11-23 18:00:31 -0600 | Rating Details | |
| 2024-11-23 09:33:27 -0600 | Rating Details | |
| 2024-11-23 06:52:48 -0600 | Rating Details | |
| 2024-11-23 03:04:26 -0600 | Rating Details | |
| 2024-11-23 02:10:49 -0600 | Rating Details | |
| 2024-11-23 02:07:39 -0600 | Rating Details | |
| 2024-11-23 01:04:57 -0600 | Rating Details | |
| 2024-11-22 22:59:02 -0600 | Rating Details | |
| 2024-11-22 22:34:55 -0600 | Rating Details | |
| 2024-11-22 22:12:10 -0600 | Rating Details | |
| 2024-11-22 21:54:49 -0600 | Rating Details | |
| 2024-11-22 21:54:07 -0600 | Rating Details | |
| 2024-11-22 21:44:43 -0600 | Rating Details | |
| 2024-11-22 21:35:44 -0600 | Rating Details | |
| 2024-11-22 20:56:08 -0600 | Rating Details | |
| 2024-11-22 20:51:24 -0600 | Rating Details | |
| 2024-11-22 20:44:00 -0600 | Rating Details | |
| 2024-11-22 18:51:34 -0600 | Rating Details | |
| 2024-11-22 18:38:50 -0600 | Rating Details | |
| 2024-11-22 18:34:07 -0600 | Rating Details | |
| 2024-11-22 18:29:50 -0600 | Rating Details | |
| 2024-11-22 18:17:44 -0600 | Rating Details | |
| 2024-11-22 18:10:19 -0600 | Rating Details | |
| 2024-11-22 17:48:00 -0600 | Rating Details | |
| 2024-11-22 17:47:10 -0600 | Rating Details | |
| 2024-11-22 16:43:16 -0600 | Rating Details | |
| 2024-11-22 16:32:59 -0600 | Rating Details | |
| 2024-11-22 16:32:31 -0600 | Rating Details | |
| 2024-11-22 16:18:12 -0600 | Rating Details | |
| 2024-11-22 16:05:04 -0600 | Rating Details | |
| 2024-11-22 15:58:05 -0600 | Rating Details | |
| 2024-11-22 15:48:35 -0600 | Rating Details | |
| 2024-11-22 15:24:04 -0600 | Rating Details | |
| 2024-11-22 15:03:51 -0600 | Rating Details | |
| 2024-11-22 14:51:21 -0600 | Rating Details | |
| 2024-11-24 01:07:02 -0600 | Rating Details | |
| 2024-11-23 03:00:20 -0600 | Rating Details | |
| 2024-11-23 02:48:21 -0600 | Rating Details | |
| 2024-11-23 01:17:53 -0600 | Rating Details | |
| 2024-11-23 00:25:40 -0600 | Rating Details | |
| 2024-11-22 23:31:09 -0600 | Rating Details | |
| 2024-11-22 22:15:42 -0600 | Rating Details | |
| 2024-11-22 18:02:49 -0600 | Rating Details | |
| 2024-11-22 17:59:37 -0600 | Rating Details | |
| 2024-11-22 17:36:14 -0600 | Rating Details | |
| 2024-11-22 17:29:14 -0600 | Rating Details | |
| 2024-11-22 17:01:22 -0600 | Rating Details | |
| 2024-11-22 16:53:19 -0600 | Rating Details | |
| 2024-11-22 16:27:03 -0600 | Rating Details | |
| 2024-11-22 16:26:36 -0600 | Rating Details | |
| 2024-11-22 15:05:27 -0600 | Rating Details |